| Features and outcomes of 899 patients with drug-induced liver injury: The DILIN prospective study N Chalasani, HL Bonkovsky, R Fontana, W Lee, A Stolz, J Talwalkar, ... Gastroenterology 148 (7), 1340-1352. e7, 2015 | 927 | 2015 |
| Genome-wide Association Study Identifies Variants Associated with Autoimmune Hepatitis Type-1 YS de Boer, NMF van Gerven, A Zwiers, BJ Verwer, B van Hoek, ... Gastroenterology 147 (2), 443-452, 2014 | 343 | 2014 |
| 17‐beta hydroxysteroid dehydrogenase 13 is a hepatic retinol dehydrogenase associated with histological features of nonalcoholic fatty liver disease Y Ma, OV Belyaeva, PM Brown, K Fujita, K Valles, S Karki, YS de Boer, ... Hepatology 69 (4), 1504-1519, 2019 | 247* | 2019 |
| Features of autoimmune hepatitis in patients with drug-induced liver injury YS de Boer, AS Kosinski, TJ Urban, Z Zhao, N Long, N Chalasani, ... Clinical Gastroenterology and Hepatology 15 (1), 103-112. e2, 2017 | 193 | 2017 |
| Autoimmune hepatitis: From current knowledge and clinical practice to future research agenda M Sebode, J Hartl, D Vergani, AW Lohse, ... Liver international 38 (1), 15-22, 2018 | 122 | 2018 |
| HLA-DRB1* 03: 01 and HLA-DRB1* 04: 01 modify the presentation and outcome in autoimmune hepatitis type-1 NMF van Gerven, YS de Boer, A Zwiers, BJ Verwer, JPH Drenth, ... Genes and immunity 16 (4), 247, 2015 | 119 | 2015 |
| Assessment of the histopathological key features in autoimmune hepatitis YS de Boer, CMJ van Nieuwkerk, BI Witte, CJJ Mulder, G Bouma, ... Histopathology 66 (3), 351-362, 2015 | 116 | 2015 |
| Expert clinical management of autoimmune hepatitis in the real world R Liberal, YS Boer, RJ Andrade, G Bouma, GN Dalekos, A Floreani, ... Alimentary Pharmacology & Therapeutics 45 (5), 723-732, 2017 | 99 | 2017 |
| Auto immune hepatitis NMF van Gerven, YS de Boer, CJJ Mulder, CMJ van Nieuwkerk, G Bouma World Journal of Gastroenterology 22 (19), 4651, 2016 | 89 | 2016 |
| Herbal and Dietary Supplement–Induced Liver Injury YS de Boer, AH Sherker Clinics in Liver Disease 21 (1), 135-149, 2017 | 79 | 2017 |
| Allopurinol safely and effectively optimises thiopurine metabolites in patients with autoimmune hepatitis YS De Boer, NMF van Gerven, NKH de Boer, CJJ Mulder, G Bouma, ... Alimentary pharmacology & therapeutics 37 (6), 640-646, 2013 | 64 | 2013 |
| Adverse events related to low dose corticosteroids in autoimmune hepatitis FF van den Brand, KS van der Veen, BI Lissenberg‐Witte, YS de Boer, ... Alimentary pharmacology & therapeutics 50 (10), 1120-1126, 2019 | 58 | 2019 |
| Seroprevalence of celiac disease in patients with autoimmune hepatitis NM van Gerven, SF Bakker, YS de Boer, BI Witte, H Bontkes, ... European journal of gastroenterology & hepatology 26 (10), 1104-1107, 2014 | 56 | 2014 |
| Increased Mortality Among Patients With vs Without Cirrhosis and Autoimmune Hepatitis FF van den Brand, KS van der Veen, YS de Boer, NM van Gerven, ... Clinical Gastroenterology and Hepatology, 2018 | 54 | 2018 |
| Association between black race and presentation and liver-related outcomes of patients with autoimmune hepatitis YS de Boer, A Gerussi, FF van den Brand, GW Wong, N Halliday, ... Clinical Gastroenterology and Hepatology, 2018 | 46 | 2018 |
| Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): an expert opinion meeting report RJ Andrade, GP Aithal, YS De Boer, R Liberal, A Gerbes, A Regev, ... Journal of hepatology, 2023 | 45 | 2023 |
| Seroprevalence of Hepatitis E Virus in Autoimmune Hepatitis Patients in the Netherlands NMF van Gerven, AA van der Eijk, SD Pas, HL Zaaijer, YS de Boer, ... J Gastrointestin Liver Dis 25 (1), 9-13, 2016 | 41 | 2016 |
| Biochemical efficacy of tioguanine in autoimmune hepatitis: a retrospective review of practice in the Netherlands FF van den Brand, CMJ van Nieuwkerk, BJ Verwer, YS de Boer, ... Alimentary pharmacology & therapeutics 48 (7), 761-767, 2018 | 32 | 2018 |
| The risk of liver cancer in autoimmune liver diseases A Lleo, YS de Boer, R Liberal, M Colombo Therapeutic Advances in Medical Oncology 11, 1758835919861914, 2019 | 27 | 2019 |
| Established and novel therapeutic options for autoimmune hepatitis R Liberal, YS de Boer, MA Heneghan The Lancet Gastroenterology & Hepatology 6 (4), 315-326, 2021 | 23 | 2021 |
